Exceptional Response of BRAF V600E -Mutated Acinar Cell CUP to BRAF/MEK Inhibition.

Authors :: Kerle IA
Scheuble AM
Kobitzsch B
Stocker G
Hiller GGR
Badendick M
William D
Krueger A
Gross T
Koegler A
Hartig A
Richter D
Aust DE
Schroeck E
Heining C
Glimm H
Hacker UT
Source :: JCO precision oncology [JCO Precis Oncol] 2024 May; Vol. 8, pp. e2400030.
Publication Year :: 2024
Abstract: Complete remission of BRAF V600E-driven ACC CUP by BRAF/MEK inhibition underscores importance of precision oncology.

Subjects :: Humans
Protein Kinase Inhibitors therapeutic use
Protein Kinase Inhibitors pharmacology
Mutation
Male
Female
Middle Aged
Mitogen-Activated Protein Kinase Kinases antagonists & inhibitors
Proto-Oncogene Proteins B-raf genetics
Proto-Oncogene Proteins B-raf antagonists & inhibitors

Full Text Access

Tools